Free shipping on all orders over $ 500

RS-127445

Cat. No. M3363
RS-127445 Structure
Synonym:

MT500

Size Price Availability Quantity
10mg USD 90  USD90 In stock
50mg USD 360  USD360 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

RS-127445 is a potent, selective and high affinity serotonin 5-HT2B receptor antagonist with a pIC50 of 10.4. The affinity (pKi) of RS-127445 for the 5-HT2B receptor is 9.5. RS-127445 is selective for the 5-HT2B receptor, having approximately 1000 fold selectivity over the human recombinant 5-HT2A, 5-HT2C, 5-HT5, 5-HT6 and 5-HT7 receptors, a 5-HT1A receptor in rat brain membranes, a 5-HT1B/D receptor in bovine caudate, and a monoamine uptake site in rabbit platelets. In the HEK-293 cells expressing the 5-HT2B receptor, RS-127445 potently antagonizes 5-HT-evoked formation of inositol phosphates (pKB=9.5±0.1) and 5-HT-evoked increases in intracellular calcium (pIC50=10.4±0.1). In addition, RS-127445 also blocks 5-HT-evoked contraction of rat isolated stomach fundus and (±) α-methyl-5-HT-mediated relaxation of the rat jugular vein with pA2 values of 9.5 and 9.9. In vivo, intraperitoneal administration of RS-127445 (5mg/kg) produces plasma concentrations predicted to fully saturate accessible 5-HT2B receptors for at least 4h. RS-127445 (0.1–10 µM) concentration-dependently reduces peristaltic frequency. RS-127445 (1–30 mg/kg), dose-dependently reduced faecal output, reaching significance at 10 and 30 mg/kg.

Protocol (for reference only)
Cell Experiment
Cell lines HEK-293 cells expressing the human 5-HT2B receptor
Preparation method Pre-incubating RS-127445, vehicle or other antagonists with 240 μl of HEK-293 cells expressing the human 5-HT2B receptor suspension at 37 °C for 20 min. Incubating HEK-293 cells with[3H]-myoinositol (1.67 μCi/ml) in 162 cm2 flasks overnight at 37 °C in an inositol free Ham's F12 medium which contains 10% dialyzed foetal bovine serum. The cells are harvested, washed five times with phosphate bufffered saline and resuspended in inositol free Ham's F12 media at density of approximately 3×103 cells/ml. The reactions are initiated by addition of 5-HT. After sixty minutes , terminating the reactions by adding 50 μl of ice-cold 20% perchloric acid, chilled in an ice-water bath for 10 min and then neutralized with 160μl of 1 N KOH. Each sample is diluted with 2 ml of 50 mM Tris-HCl, pH 7.4 at room temperature. The aqueous portion (2.2 ml) is transferred onto Dowex AG1X8 columns (1 ml, 1 : 1, w/v) which has been washed with 5 ml of distilled water. Then washing the columns with 18 ml of distilled water and eluting the inositol phosphates with 3 ml of 1 N HCl.Using a Packard 1900CA analyzer to determine the eluted radioactivity by liquid scintillation spectroscopy.
Concentrations 10 μM
Incubation time 20 min
Animal Experiment
Animal models rats
Formulation ethanol:pro-pylene glycol : water (10 : 50 : 40, v/v/v)
Dosages 5 mg/kg
Administration Oral for 2.5 h ,intraperitoneal and intravenousroutes for 0.08 h
Chemical Information
Molecular Weight 281.33
Formula C17H16FN3
CAS Number 199864-87-3
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Adeline Cathala, et al. Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways

[2] Cline Devroye, et al. Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin 2B receptor blockade: Involvement of medial prefrontal cortex serotonin 1A receptors

[3] Cline Devroye, et al. Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow

[4] A K Bassil, et al. Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology

[5] D W Bonhaus, et al. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist

Related 5-HT Receptor Products
TC-2153

TC-2153 is a selective inhibitor of striatal-enriched protein tyrosine phosphatase (STEP). TC-2153 also inhibits 5-HT2A receptor-mediated signaling.

Gentisein

Gentisein (NSC-329491), the major metabolite of Mangiferin, shows the most potent serotonin uptake inhibition with an IC50 value of 4.7 µM.

MM120

MM120 is a synthetic tryptamine that is also a partial agonist at the 5-hydroxytryptamine 2A (5-HT2A) receptor. It can be used in studies related to GAD and attention deficit hyperactivity disorder (ADHD).

SB 258741 hydrochloride

SB 258741 hydrochloride is a specific 5-HT7 receptor antagonist for schizophrenia.

5-HT1A antagonist 1

5-HT1A antagonist 1 is a potent and selective 5-HT1A receptor antagonist with a Ki value of 35 nM.5-HT1A antagonist 1 can be used in the study of central nervous system disorders.

  Catalog
Abmole Inhibitor Catalog




Keywords: RS-127445, MT500 supplier, 5-HT Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.